Drug targeting of heme proteins ion Mycobacterium tuberculosis

被引:17
|
作者
McLean, Kirsty J. [1 ]
Munro, Andrew W. [1 ]
机构
[1] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, 131 Princess St, Manchester M1 7DN, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
CHOLESTEROL CATABOLIC PATHWAY; CATALASE-PEROXIDASE GENE; CELL-WALL; TRUNCATED HEMOGLOBIN; TRANSCRIPTIONAL REGULATION; ISONIAZID RESISTANCE; CYP121; INHIBITORS; MEMBRANE-PROTEINS; IRON-METABOLISM; KATG EXPRESSION;
D O I
10.1016/j.drudis.2016.11.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
TB, caused by the human pathogen Mycobacterium tuberculosis (Mtb), causes more deaths than any other infectious disease. Iron is crucial for Mtb to infect the host and to sustain infection, with Mtb encoding large numbers of iron-binding proteins. Many of these are hemoproteins with key roles, including defense against oxidative stress, cellular signaling and regulation, host cholesterol metabolism, and respiratory processes. Various heme enzymes in Mtb are validated drug targets and/or products of genes essential for bacterial viability or survival in the host. Here, we review the structure, function, and druggability of key Mtb heme enzymes and strategies used for their inhibition.
引用
收藏
页码:566 / 575
页数:10
相关论文
共 50 条
  • [41] The road to drug resistance in Mycobacterium tuberculosis
    Koch, Anastasia
    Wilkinson, Robert John
    GENOME BIOLOGY, 2014, 15 (11):
  • [42] Mycobacterium tuberculosis drug resistance, Ghana
    Owusu-Dabo, Ellis
    Adjei, Ohene
    Meyer, Christian G.
    Horstmann, Rolf D.
    Enimil, Anthony
    Kruppa, Thomas F.
    Bonsu, Frank
    Browne, Edmund N. L.
    Chinbuah, Margaret Amanua
    Osei, Ivy
    Gyapong, John
    Berberich, Christof
    Kubica, Tanja
    Niemann, Stefan
    Ruesch-Gerdes, Sabine
    EMERGING INFECTIOUS DISEASES, 2006, 12 (07) : 1170 - 1172
  • [43] Mechanisms of Mycobacterium tuberculosis Drug Resistance
    Shulgina, M. V.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2024, 39 (01) : 1 - 13
  • [44] Mycobacterium tuberculosis drug resistance, Abkhazia
    Pardini, M
    Iona, E
    Varaine, F
    Karakozlan, H
    Arzumanian, H
    Brunori, L
    Orefici, G
    Fattorini, L
    EMERGING INFECTIOUS DISEASES, 2005, 11 (03) : 501 - 503
  • [45] Mechanisms of drug resistance in mycobacterium tuberculosis
    Wade, MM
    Zhang, Y
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 975 - 994
  • [46] Drug Resistance Mechanisms in Mycobacterium tuberculosis
    Palomino, Juan Carlos
    Martin, Anandi
    ANTIBIOTICS-BASEL, 2014, 3 (03): : 317 - 340
  • [47] Mechanisms of drug resistance in Mycobacterium tuberculosis
    Zhang, Y.
    Yew, W. W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (11) : 1320 - 1330
  • [48] DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN CHANDIGARH
    MAHAJAN, RC
    AGARWAL, SC
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1968, 56 (08) : 1180 - &
  • [49] The progress of Mycobacterium tuberculosis drug targets
    Zhang, Xin
    Zhao, Ruixia
    Qi, Yao
    Yan, Xiong
    Qi, Gaoxiu
    Peng, Qiuju
    FRONTIERS IN MEDICINE, 2024, 11
  • [50] The road to drug resistance in Mycobacterium tuberculosis
    Anastasia Koch
    Robert John Wilkinson
    Genome Biology, 15